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1 INTRODUCTION
Predicting genetic interactions from Boolean models of biological net-
works
Laurence Calzone,a,b,c,d Emmanuel Barillot,a,b,c,e and Andrei Zinovyeva,b,c, f
Abstract: Genetic interaction can be defined as a deviation of the phenotypic quantitative effect of a double gene mutation
from the effect predicted from single mutations using a simple (e.g., multiplicative or linear additive) statistical model. Exper-
imentally characterized genetic interaction networks in model organisms provide important insights into relationships between
different biological functions. We describe a computational methodology allowing to systematically and quantitatively character-
ize a Boolean mathematical model of a biological network in terms of genetic interactions between all loss of function and gain of
function mutations with respect to all model phenotypes or outputs. We use the probabilistic framework defined in MaBoSS soft-
ware, based on continuous time Markov chains and stochastic simulations. In addition, we suggest several computational tools
for studying the distribution of double mutants in the space of model phenotype probabilities. We demonstrate this methodology
on three published models for each of which we derive the genetic interaction networks and analyze their properties. We classify
the obtained interactions according to their class of epistasis, dependence on the chosen initial conditions and phenotype. The use
of this methodology for validating mathematical models from experimental data and designing new experiments is discussed.†
1 Introduction
Genetic interaction is defined as a phenomenon by which the
effect of a double gene mutation cannot be predicted from the
effect of single mutations using a simple (such as additive or
multiplicative) statistical model15,25,32. The strength of the in-
teraction can be characterized by an epistatic score, which is,
in the case of purely deleterious mutations, negative for syn-
ergistic interactions (when the phenotype of a double mutation
is significantly stronger than the expected combined effect of
two independent single mutations), and positive for alleviating
interactions (when the combined effect is weaker). Examples
of synergistic interactions are synthetic lethality and synthetic
sickness (in the case of survival-related phenotype) or synthetic
enhancement of a phenotype4,21. An example of strong allevi-
ating interaction is the suppression of an effect of one mutation
by a second mutation (in classical genetics, such interactions
were historically defined as “epistatic”). Genetic interactions
in the general case of both beneficial and deleterious mutations
can be classified into 9 groups according to various inequality
relations between the effects of single and double mutants12.
Genetic interaction networks provide important insights into
relations between different biological functions36. Knowledge
of genetic interactions with respect to a disease phenotype
can provide important hints on personalized treatment strat-
egy, in particular, in cancer1,23,28. This knowledge is cur-
rently obtained by costly high-throughput screening techniques
based on knocking-out or knocking-down genes (using siRNA
or shRNA) in model organisms, such as yeast11,38, worm6,
mouse13 or human cells27. Experimentally, one can measure
both synthetic and synthetic dosage interactions31. Establish-
ing single genetic interactions can be a result of long and te-
dious work, in the case of phenotypes that are complex and
difficult to observe such as metastasis8.
Computational approaches have been used in order to de-
rive genetic interactions from dynamical mathematical models
or by using machine learning approaches. One of the earli-
est attempts to characterize the genetic networks of the genes
involved in metabolism was done using flux balance analysis
framework applied to a genome-wide reconstruction of yeast
metabolic network32. In this work, the quantitative epistatic
measure was introduced to characterize the genetic interactions
as a difference between the observed effect of a double mutant
and the multiplicative model prediction from the effect of two
single mutation effects. It was noted that the distribution of
the epistatic measure is tri-modal and that the interactions be-
tween functional modules have a tendency for monochromatic-
ity, i.e., having the same dominant sign for between-module
interactions. In a recent paper, a similar approach was ap-
plied to characterize genetic interactions with respect to mul-
tiple metabolism-related phenotypes33.
There have been many attempts to apply machine learn-
ing approach for predicting genetic interactions from a subset
of known interactions5,35. For instance, in yeast, the struc-
ture of physical interaction networks was combined with co-
expression networks; data on protein classification was used for
predicting genetic interactions40. In worm, identical anatomi-
cal expression and microarray co-expression, phenotype prox-
imity, Gene Ontology annotation and presence of interlogs
were the parameters used for fitting the logistic regression in
order to score genetic interactions42. Decision tree-based ap-
proaches trained on the structure of protein-protein interaction
and co-expression networks in both yeast and worm were also
used9. Short polypeptide cluster detection was utilized to pre-
dict synthetic lethal interactions between genes in yeast41. Still
in yeast, evolutionary approaches and the notion of functional
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asymmetry allowed prediction of negative genetic interactions
between protein complex components24. There are very few
examples of computational predictions of genetic interactions
in human, one of them used gene expression analysis to predict
synthetic lethal partners of TP53 gene39. The main problem
of most of machine learning approaches is the absence of bona
fide negative example (absence of interaction) set for training,
which is usually needed for a successful application of auto-
mated classification methods5. Nevertheless, it was shown that
machine learning methods are able to predict genetic interac-
tions significantly better than random choice of a gene pair.
The knowledge about molecular mechanisms involved in a
biological phenomenon that one wishes to study can be repre-
sented as a network of interacting entities30. Depending on the
network type, the translation into a mathematical model can be
done using an appropriate formalism (ordinary or partial dif-
ferential equations, logical, rule-based modeling, etc.). These
mathematical models can predict the effect of a perturbation,
intrinsic or extrinsic, and anticipate the response of a drug, for
instance. Boolean (or, more generally, logical) modeling fo-
cuses on how the influences of regulatory molecules combine
to control the expression or activity of each molecular entity
- or process - composing the regulatory network. In a purely
Boolean framework, each variable of the model can only take
two values: 0 or 1 (absent/inactive or present/active). In our
studies, we found that Boolean formalism represents a conve-
nient mean of abstraction for modeling cellular biochemistry
dynamics and verifying that the topology of the networks repre-
senting the studied phenomena fits the experimentally-observed
effects of loss or gain of function mutations on a phenotype. So
far, there was no attempt to systematically predict genetic in-
teractions using Boolean models of biological mechanisms.
An important remark should be made with respect to any at-
tempt to predict the genetic interactions computationally. Ge-
netic interactions, being functional rather than physical, can
strongly depend on the choice of both the phenotype (or model
read-out) and the set of initial conditions used for model simu-
lations. Therefore, genetic interactions can be classified as oc-
curring with respect to single versus multiple phenotypes, and
dependent versus independent on initial conditions. With the
mathematical model of metabolism in yeast, it was shown that
genetic interactions synergistic with respect to one phenotype
can become alleviating with respect to another one33. Simi-
larly, depending on the set of initial conditions (accounting for
homeostatic, physiological, nutrient-deprived, etc. conditions),
some phenotypes represented in the model can never be reached
or the simulations can lead to a different output with the same
set of inputs. For example, in a model of cell fate decision pro-
cess in response to TNF (or Fas) ligand activation signal, the
cell response showed to be either survival or cell death (non-
apoptotic and apoptotic with a higher probability for necrotic
phenotype though) depending on the activity of some nodes of
the model7. In a model describing the kinetics of the restriction
point, if the G1 cell cycle phase cyclin, Cyclin D1 (CycD in the
model), is initially active (corresponding to presence of growth
factors), the cell enters the cycle, otherwise, it stays stuck in G1
arrest14,29.
In this manuscript, we suggest a quantitative methodology to
convert a logical model of a regulatory network into a genetic
interaction network, defined with respect to a chosen model
phenotype (which can be any phenotype and not only survival-
related as it is often the case). The methodology is based on
using the formalism of continuous time Markov chains imple-
mented in MaBoSS software37. Using published models, we
applied our method to derive several genetic interaction net-
works for the genes that compose these models. We analyze
genetic network properties and show that they possess many
features of experimentally-measured genetic networks. The de-
rived genetic interactions reflect the functional properties of the
mathematical models studied, so we briefly compare these pre-
dicted functional relations using available databases.
2 Methods and data
2.1 Models used in this study
Three published models were selected for testing the method.
The models correspond to signalling pathways involved in can-
cer with the focus on: the MAPK pathway20 describing the
crosstalk between the three mitogen-activated protein kinases:
ERK, p38 and JNK, and their role in apoptosis and proliferation
balance; the cell cycle with the focus on the biochemical pro-
cesses regulating the restriction point14,29; and cell fate deci-
sion between survival and death in response to extrinsic signals
such as death receptor activation7,44.
For each of the model, we provide the models in both GIN-
sim26 and MaBoSS37 formats. Several genetic interaction net-
works (GINs) per model can be constructed corresponding to
different initial conditions and to the chosen phenotype. They
can be found as separate Cytoscape sessions in Supplementary
materials (Supp Mat GINs).
2.2 Computing phenotype probabilities
For each model, we computed the probability of reaching
model phenotypes for all possible single and double mutants
(resulting either from gain of function - modelled as fixing
† Electronic Supplementary Information (ESI) available:
http://maboss.curie.fr/gins. See DOI: 10.1039/b000000x/
a Institut Curie, 26 rue d’Ulm, Paris, France
b INSERM U900. Paris, France.
c Mines ParisTech, Fontainbleau, France
d E-mail: Laurence.Calzone@curie.fr
e E-mail: Emmanuel.Barillot@curie.fr
f E-mail: Andrei.Zinovyev@curie.fr
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the corresponding node value to 1, and referred to as ”over-
expression” or ”oe”, or from loss of function - modelled as fix-
ing the node value to 0 and referred to as ”deletion” or ”ko”).
For these computations, we used both MaBoSS software and
a set of scripts for processing the MaBoSS configuration and
output files, implemented into BiNoM Cytoscape plugin2,3,43.
MaBoSS is a C++ software designed for simulating continu-
ous/discrete time Markov processes, defined on the state tran-
sition graph representing the dynamics of a Boolean network.
MaBoSS allows the modeller to associate different rates up and
rates down to each variable of the model when the dynamics
is known, enabling to account for different time scales of the
processes described by the model. Given some initial condi-
tions, MaBoSS computes time trajectories by applying Monte
Carlo kinetics algorithm (Details and examples can be found
at: http://maboss.curie.fr). More precisely, probabili-
ties to reach a phenotype are computed as the probability for
the variable associated to the phenotype to have the value 1, by
simulating random walks on the probabilistic state transition
graph. The parameters for the stochastic simulations (number
of runs, initial conditions, maximum time, etc.) are configured
for each simulation. The read-out can be a variable represent-
ing the phenotype, a variable representing a protein or gene, or
a combination of them. The probabilities for the selected out-
puts are reported for each mutant based on predefined initial
conditions (which can be all random). Since a state in the state
transition graph can combine activation of several phenotype
variables, some phenotype probabilities appear to be “mixed”
or coupled. It is particularly the case for cyclic attractors. For
the cell fate model, we investigated the effect of the choice of
the initial conditions (“random” versus “physiological”) on the
final phenotype probability distribution. The result of the sim-
ulations is stored in a simple table, containing the complete set
of mutants characterized by probabilities of all pure and mixed
model phenotypes (in Supp Mat Models and Supp Mat GINs).
2.3 Quantifying epistasis in double mutants
2.3.1 Definition of epistasis measures.
The results of double mutant simulations were used to quan-
tify the level of epistasis between two model gene defects A
and B with respect to a particular phenotype φ . We define the
normalized “fitness” of a mutation (or combination of muta-
tions) X with respect to a phenotype φ as the ratio between the
probability of the phenotype in the mutant X and the wild-type
models.
f Xφ =
pXφ
pwtφ
. (1)
To fully characterize a genetic interaction, one should be able
to characterize its strength and type. We defined the strength of
the interaction as a deviation of the fitness of the double mutant
from one of the four simplest statistical models frequently used
in this context: additive, logarithmic, multiplicative and min ,
i.e.,
εφ (A,B) = f ABφ −ψ( f Aφ , f Bφ ). (2)
where f Aφ and f Bφ are phenotype φ fitness values of single gene
defects, f ABφ is the phenotype φ fitness of the double mutant,
and ψ(x,y) is one of the four functions:
ψADD(x,y) = x+ y (additive)
ψLOG(x,y) = log2((2x− 1)(2y− 1)+ 1) (log)
ψMLT (x,y) = xy (multiplicative)
ψMIN(x,y) = min(x,y) (min)
(3)
To choose the best definition of ψ(x,y), the Pearson corre-
lation coefficient was computed between the fitness values ob-
served in all double mutants and estimated by the null model.
The null model with maximal linear correlation was chosen:
ψ(x,y) = argmax
ψ(i)
corr(ψ(i)( f Aφ , f Bφ ), f ABφ ),
i = ADD,MLT,LOG,MIN.
(4)
Note that the best definition of ψ can vary from model to
model, from phenotype to phenotype, and even for different
choices of initial conditions. Our simulations show that ψLOG
performs uniformly optimal or close to optimal in most of the
simulations, having also advantage of not producing biased dis-
tributions of ε (see next section).
2.3.2 Removing bias in the distribution of epistatic mea-
sure values.
After computing the distribution of epistatic measures, it can
be observed that the peak of the distribution is shifted towards
non-zero epistasis. This can be considered as a bias in esti-
mating the null multiplicative model for quantifying the epista-
sis measure (2). In our experiments, it was corrected by lin-
ear fitting of the observed value y = f AB to the null model
x = ψ( f A, f B) (see Figure 1B). Then the epistatic measure is
defined as:
ε
(corrected)
φ (A,B) = f ABφ −αψ( f Aφ , f Bφ ), (5)
where α is the slope coefficient in the best linear fit estimation
∑ ||y−αx||2 → min. Further in the text, we refer to ε(corrected)
as ε unless explicitly specified.
2.3.3 Choosing the threshold for defining the set of ge-
netic interactions.
The distribution of the epistasis measures ε is asymmetric
in many examples. Therefore, we set a threshold separately
3
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Fig. 1 Illustrating epistasis measures for cell fate decision model. A) distribution of ε values for three phenotypes. B) Additive model of
epistasis, solid line shows uncorrected additive null model and dashed line shows the corrected model; an arrow shows a particular double
mutant BAX+/BCL2+, for which the combined effect is stronger than expected by the null model (example of single-nonmonotonic genetic
interaction, A <W T < B < AB); the length of the arrow equals to ε(BAX +/BCL2+) in this case. C) comparison between ε values for the
case of random initial conditions and the physiological initial condition. D) comparison between ε values for two different cell death
phenotypes.
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for positive and negative part of epistastis measure distribu-
tion (Figure 1A) as a multiplier of one-tailed standard devia-
tions. Those genetic interactions whose strength are above k
one-tailed standard deviations are selected, where k is a real
number parameter (typically, k = 2 as a moderately stringent
selection criterion).
2.3.4 Defining the type of genetic interaction.
Since in model simulations, one can have both deleterious
f X < 1, neutral f X ≈ 1 and beneficial f X > 1 mutations X with
respect to a phenotype φ , multiple possibilities arise for rela-
tions between four numbers f A, f B, f AB and fW T = 1 which
cannot be simply grouped into alleviating and aggravating, as
in the simplest case of pure deleterious mutations. We classi-
fied gene interactions using the existing approach12, according
to 75 possible inequalities between these four numbers which
are further grouped into 9 genetic interaction classes: “sup-
pressive”, “epistatic”, “conditional”, “single-nonmonotonic”,
“additive”, “double-nonmonotonic”, “non-interactive”, “syn-
thetic”, “asynthetic”. The first 4 classes in this list can be char-
acterized by a direction of the interaction, i.e., mutation A is
epistatic to B means that the effect of A completely cancels the
effect of B (and both effects are different from the wild-type),
and not the opposite (A → B). Note that the directed genetic
interaction maps the causal effects in opposite direction (e.g.,
mutations in downstream effectors of a phenotype can mask
more upstream mutations).
To define inequalities, we introduced a threshold for distin-
guishing different values of fitness f , i.e., we consider two val-
ues of fitness f A and f B equal, if | f A − f B| < δ , where we
typically choose δ = 0.2.
For example, one of the most prevalent interactions in our
simulations is the “epistatic” (in the sense of the classical defi-
nition of the notion “epistasis”) interaction which corresponds
to inequalities B < WT < A = AB (denoting f B < fW T = 1 <
f A = f AB) or A = AB < WT < B meaning that the effects
of single mutants are opposite with respect to the wild-type
(one is deleterious and another is beneficial) and the effect of
the double mutant is equal to one of the single mutants (one
single mutant “wins”). Another interesting example is “syn-
thetic” interaction type which can correspond to the inequal-
ity AB < W T = A = B (classical “synthetic sickness”) or to
WT = A = B < AB (“synthetic enhancement”).
Some interaction types are counter-intuitive such as “single-
nonmonotonic” which can correspond to the inequality A <
WT < B < AB, when a combination of deleterious and bene-
ficial mutations lead to enhancement of the phenotype stronger
than the beneficial mutation alone. It was shown that these in-
teractions are observed in real data12, and they are also ob-
served in some of our simulations (see Figure 2).
2.3.5 Visualizing genetic interaction network using Cy-
toscape.
additive: WT<B<A<AB; B<WT<AB<A; WT<A<B<AB; A<AB<WT<B; 
        B<AB<WT<A; AB<B<A<WT; AB<A=B<WT 
epistatic: A=AB<WT<B; WT<A=AB<B; WT<B<A=AB; B<WT<A=AB;  
asynthetic: WT<A=B=AB; A=B=AB<WT 
single-nonmonotonic: A<WT<B<AB; WT<A<AB<B; AB<B<WT<A 
conditional: WT=B<A<AB; WT=B<AB<A; A<AB<WT=B; A<WT=B<AB 
synthetic: WT=A=B<AB; WT<A=B=AB; AB<WT=A=B 
suppressive: WT=A=AB<B; B<WT=A=AB 
non-interactive: B=AB<WT=A; WT=A<B=AB; WT=B<A=AB; WT=A=B=AB 
gain-of-function 
loss-of-function 
Legend 
double-nonmonotonic: WT<AB<B<A; AB<WT<B<A; WT=AB<B<A   
Fig. 3 Colour code for the genetic interaction networks. The name of
the interaction and the colour code is in accordance with12. Only the
rules found in our analyses of the three models are indicated for each
interaction
The selected genetic interactions are visualized in Cy-
toscape10 (see example with Figure 5 and Figure 2). The vi-
sual mapping chosen distinguishes, by colour and shape, loss
of function and gain of function single mutants. Size of the
nodes reflects the effect on the phenotype of a single mutant,
and the width of the edge, the epistatic effect strength of the
corresponding double mutant. Colouring edges denotes their
types, using the colour schema suggested before12 (see Fig-
ure 3 for definition of the visualization style).
2.3.6 Using non-linear principal component analysis for
mapping double mutant distribution in the space of phe-
notype probabilitiesThe non-linear principal manifolds were
constructed for the distribution of all single and double mu-
tants of the model in the space of computed model phenotype
probabilities, using elastic maps method16–18 and ViDaExpert
software19. For computation, only the mixed phenotypes with
a probability expectation over the whole set of double mutants
with more than 1% were selected. This results in sets of double
mutants in multi-dimensional space for which principal mani-
folds were computed (see Figure 4).
3 Results and discussion
The three Boolean models were downloaded either from The
Cell Collective database22 or from GINsim database26. The
stable state analysis was done in GINsim software. The mod-
els were then exported in MaBoSS for simulations. Finally,
we used some scripts embedded into BiNoM cytoscape plu-
gin to automatically compute probabilities for all single and
double mutants (including both gain of function and loss of
function mutants for all components of each model) and vi-
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Fig. 2 Genetic interaction networks computed for cell fate decision model, with random and physiological initial conditions and for the three
considered phenotypes: apoptosis, necrosis and survival
6
3 RESULTS AND DISCUSSION 3.1 Cell fate decision model
Fig. 4 Application of non-linear principal manifold analysis for
visualizing the distribution of double mutants in the space of
phenotype probabilities. The figure shows projection of phenotype
probabilities from multi-dimensional space onto the 2D space of
internal coordinates of the non-linear principal manifold. Each point
corresponds to a mutant. A big violet pentagon coresponds to the
wild-type model, triangles to single-element mutant model and
circles to double mutants. Gradients of increase of the model
phenotypes probabilities are shown by curved arrows. The gray color
in the background visualizes local density of the projections onto the
map, allowing to perform cluster analysis visually.
sualize the results of paired interactions as genetic interaction
networks. A thorough description of each model is given in
supplementary materials (SuppMat description models) along
with the Cytoscape sessions for each model, each phenotype
and different initial conditions for one of the models (Supp-
Mat GINs).
3.1 Cell fate decision model
Figure 2 shows the genetic interaction networks computed with
respect to three different phenotypes (survival, apoptosis, non-
apoptotic cell death referred to as necrosis for short)7.
The general shape of the epistatic measure distribution ex-
hibit tri-modality (Figure 1A), as it was previously observed in
another modeling framework32. The cell fate decision GINs
and the distributions of ε show that the networks computed for
different phenotypes are less similar than the networks com-
puted for the same phenotype but with different initial condi-
tions (Figures 2 and 1C,D, with the legend for GINs given in
Figure 3). Similar conclusions were made for most of the con-
structed GINs in this study.
For the physiological initial conditions with TNF=1, some
gene alterations (and, by extension, some pathways) appear to
be more important than when all initial conditions are consid-
ered. Indeed, some of these interactions are lost in the nu-
merous genetic interactions when considering all initial con-
ditions. It is particularly evident for the survival phenotype.
Overexpressing any gene from the survival pathway, which is
described in a linear manner in this model is enough to favour
or even force the survival phenotype. When taking in account
all possible inputs, other pathways can help reach the survival
phenotype: the additive effect of both RIP1 and cIAP gain
of function would be equivalent to forcing RIP1ub. Single-
nonmonotonic interactions are found numerous in the apop-
totic and necrotic genetic networks. Unexpectedly, the gain of
function of BCL2, which leads to a null probability of reaching
apoptosis, together with the gain of function of BAX increases
the apoptotic probability of BAX gain of function alone. In
fact, BCL2 gain of function is able to block very efficiently
both apoptosis and necrosis. If BAX gain of function promotes
apoptosis as observed experimentally, deleting any signal from
the necrotic (or necroptotic) pathway seems to increase apop-
tosis even more. This observation confirms the mutual exclu-
sive nature of the two phenotypes. In accordance with Drees
et al.12, this type of single-nonmonotonic interactions occur
with a high frequency in our networks but also in experimental
data even though they are not “recognized by common genetic
nomenclature”.
The distribution of all single and double mutant models
forms a set of points in the multi-dimensional space of model
phenotype probabilities. We found it very informative to vi-
sualize this set with the projection from multi-dimensional to
7
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two-dimensional space, using advanced methods of non-linear
data visualization such as the projection onto the principal man-
ifolds constructed by the elastic maps method (Figure 4). In
these visualizations, one can see that single and double mutants
form clusters characterized by some typical phenotype proba-
bility values. The cluster around the wild-type model, collects
those mutants whose effect can be considered as neutral. Some
clusters represent the mutants with extreme effect of induction
of some of the phenotypes. The probability of different pheno-
types changes along the non-linear directions (gradients) of in-
creasing phenotype probability. Some clusters, labelled here by
“BCL2 oe” and “ROS ko” single mutants, correspond to some
particular states of the model (“naive survival” for “BCL2 oe”
and a complex state combining apoptosis and “naive survival”
for “ROS ko”: note that the last state can be artificial due to
some irrealistic assumptions such as non-production of ROS,
over-abundance of ATP, or impossibility of MPT).
3.2 MAPK model
The MAPK pathway controls several cellular processes such as
cell cycle activation, apoptosis, survival or differentiation. The
model of Grieco et al.20 details the crosstalk between the path-
ways of the three mitogen-activated protein kinases: ERK, JNK
and p38. In response to four stimuli (EGFR, FGFR3, TGFbeta,
and DNA damage), the model produces in silico the cell re-
sponse in terms of proliferation, growth arrest and apoptosis
in diverse conditions, and simulates different sets of mutations
often found in cancer. Even though the model is generic, its
analysis is applied to studying bladder cancerogenesis.
Three GINs are generated using stringent conditions (inter-
actions are selected above k = 3 standard deviations) for filter-
ing the edges for the three phenotypes: apoptosis, growth arrest
and proliferation. The networks are characterized by modular
structure, in particular, for the apoptotic phenotype (Figure 5,
panel 1). Interestingly, interactions within some modules or
between modules are monochromatic with respect to the type
of the genetic interactions. For example, a module connect-
ing several transcription factors (JUN, AP1, ATF2) with phos-
phatase PPP2CA negatively controlling cell growth appears in
the GINs for both the apoptosis and growth arrest phenotypes.
All interactions inside this module are of “synthetic” type (i.e.,
synergistic). Monochromatic structure of interactions between
modules can be seen in Figure 5, panel 3, where the network
can be decomposed into several modules (e.g., PTEN/p21/AKT
versus p70/ERK/MEK1 2) based on the same type of interac-
tions in between them.
Genes of the apoptotic pathway such as ATM, MAX, etc. ap-
pear to be hubs in the network with the emphasis on ATM and
conditions for the two following situations: loss of function or
gain of function of ATM and the partners that contribute to in-
creasing (or compensating for the loss of) apoptosis (Figure 5,
panel 1). The combination of p53 gain of function and ERK
gain of function seems to be a good combination to improve
the growth arrest phenotype (Figure 5, panel 2) whereas loss of
function of PTEN reduces the arrest caused by gain of function
of BCL2. In the GIN for the proliferation phenotype (Figure 5,
panel 3), the gain of function of either MEK1 2 or ERK seems
to be crucial in promoting proliferation, particularly in combi-
nation with gain of function of AKT or loss of function of p53
or p38, for instance. They form a hub in the network and seem
to be very similar (symmetric) in terms of genetic interactions
they share with the rest of the proteins of the network.
The MAPK model is the biggest network we study here. We
anticipate that in even bigger regulatory network models, the
corresponding genetic interaction networks should be modular
and provide informative hints on pathways that are activated
with respect to a particular phenotype. Predictions about the
co-occurrence or the mutual exclusivity between gene alter-
ations could be also derived from these networks.
3.3 Mammalian restriction point model
This Boolean model14 was adapted from a mathematical model
based on ordinary differential equations developed by Novak
and Tyson29. The model was built to illustrate the behaviour
of cells exposed to cycloheximide treatments at different times
of the cell cycle. The model describes the dynamics of the re-
striction point situated in late G1 after which the cell commits
to division even if treated by the drug.
For this small model, the GINs are easier to interpret biologi-
cally (Figure 6). The model is built such that if the cell does not
receive any external growth signals, of which CycD is the sen-
sor, it remains stuck in G1 cell cycle phase. Therefore, neither
CycD nor Rb are included in these networks as their gain or loss
of function would automatically lead to forcing or deleting the
phenotypes. The gain of function of the cell cycle inhibitor p27
is counteracted by the gain of function of downstream cyclins
such as CycA and CycE. Similarly, if both inhibitors of the G2
and M cyclins are deleted, Cdc20 and cdh1, it is equivalent to
overexpressing the cyclins and the cells can no longer arrest.
A similar mechanism is achieved by overexpressing E2F and
deleting cdh1. The role of cdh1 seems to be more prevalent in
degrading the cyclins. Note that cdh1 and Cdc20 are in both
genetic interaction networks for growth arrest and proliferation
because the two read-outs are symmetric. The loss of function
of both Cdc20 and cdh1 leads to a very low probability of ar-
resting the cycle, and a very high probability for proliferating.
The two phenotypes are mutually exclusive.
3 RESULTS AND DISCUSSION 3.3 Mammalian restriction point model
Fig. 5 Genetic interaction networks computed for MAPK model,
with random initial conditions and for the three phenotypes:
apoptosis, growth arrest and proliferation
Fig. 6 Genetic interaction networks computed for restriction point
model, with random initial conditions and for the two phenotypes:
growth arrest and proliferation
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3.4 Comparison with experimentally derived genetic in-
teractions
We performed two types of comparisons: first, we compared
the genetic interactions from our method to available experi-
mental results, and second, we compared the genetic interac-
tions between models.
We have compared the results from each of the examples we
have chosen in this analysis with genetic interactions listed in
BioGRID database34. In the database, we queried the genes
that appeared as participating in pairs of genetic interactions
in a significant manner in our three models. We found that in
the MAPK model, TP53 and MDM2 interactions came out in
both BioGRID and our study: TP53 and MDM2 were identi-
fied in a phenotypic suppression type of genetic interaction in
BioGRID and we showed that overexpression of both TP53 and
of MDM2 led to a suppressive genetic interaction with respect
to the apoptosis phenotype. The pair ATM and TP53 seems to
be involved in a phenotypic enhancement in BioGRID, but was
not found in our study. In the cell fate model, we listed three
phenotypic suppressions between XIAP and CASP8, IKK1 and
TNF, and BCL2 and CASP8. The first two were confirmed in
our analysis: overexpression of XIAP and of CASP8 lead to
an epistatic interaction with respect to apoptosis in the TNF-
activated signal, and deletion of IKK1 and deletion of TNF
lead to an epistatic interaction with respect to the necrosis
(NonACD) phenotype in the TNF-activated signal. Also, over-
expression of IKK1 and deletion of TNF lead to an epistatic
interaction with respect to the survival phenotype in the TNF-
activated signal. The last interaction was not identified with our
method. In the mammalian restriction point model, there was
only one interaction that appeared in BioGRID and involved
a phenotypic enhancement between p21 and p27 which was
not found in our analysis. More details can be found in sup-
plementary materials, SuppMat Analysis BioGRID. In conclu-
sion, the comparison showed that some interactions predicted
by our method were indeed confirmed in BioGRID database.
This type of comparison can serve to validate Boolean models
developed for various molecular mechanisms with respect to
known genetic interactions and provide additional constraints
on the choice of model network topology, logical rules and rate
parameters. Of course, in this analysis one should take into ac-
count incompleteness of our knowledge on genetic interactions.
We also compared more in detail the results of the genetic
interactions among the three examples. Unfortunately, there
was no overlap between the three models since the only com-
mon gene was BCL2 between the cell fate and the MAPK
models. We then looked more carefully at the genetic inter-
actions between phenotypes but for each model individually.
With this comparison, we identified the complementary role of
some genes in the networks and confirmed findings from the
initial publications. The results can be found in supplementary
materials, SuppMat comparison phenotypes.
4 Conclusions
In this manuscript, we suggest a methodology for converting
a logical mathematical model with a set of initial conditions
into the corresponding genetic interaction network characteriz-
ing the behaviour of all single and double mutants in terms of
phenotype probabilities. The advantage of the methodology is
in that it allows:
1) estimating and classifying possible functional interactions
between the different elements composing the model;
2) distinguishing extreme cases of mutations amplifying or
masking each other and, based on this, suggesting intervention
points in order to achieve a desired phenotype (such as in8);
3) suggesting experimental designs from the logical models;
4) detecting controversial (non-intuitive) properties of mu-
tants with respect to expected phenotypes such as nonmono-
tonic genetic interactions;
5) comparing quickly similar logical network models in
terms of their functional properties;
6) validating the model and comparing different models us-
ing available screenings for genetic interactions (such as syn-
thetic lethality screens).
The last point deserves further development. We aim at ex-
tending our methodology using existing databases containing
genetic interactions (similar to what we did with BioGRID34)
for matching the model predictions with genetic interactions or
single mutation phenotypes known from the literature or from
screenings. Moreover, similar to the methodology of param-
eter fitting in constructing chemical kinetic models, one can
fit the kinetic rates defined in our continuous-time discrete ap-
proach37 in order to optimize the set of model predictions.
Another set of experimental data that could be used with this
approach is high-throughput cancer data, such as large-scale
mutation landscapes that are collected for series of tumours.
Patterns of co-occurrence or mutual exclusivity of mutations
can reflect action of genetic interactions in cancer cells. For
example, synthetically lethal interactions can lead to the pat-
tern of mutual exclusivity since cancer cells possessing both
synthetically lethal mutations will be eliminated from the cell
population. Using these data for interpretation and validation
of model-based predictions requires the development of a sta-
tistical methodology for detecting statistical patterns in high-
throughput data.
Genetic interaction networks reconstructed from log-
ical mathematical models possess many properties of
experimentally-measured networks. They are characterized by
a variety of types of genetic interactions (with predominance
of masking, e.g., epistatic interactions), modular structure for
sufficiently big discrete models (Figure 5), with some modules
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characterized by monochromaticity for within-module interac-
tions as well as between-module interactions. Sets of genetic
interactions are highly dependent on the phenotype with re-
spect to which they are defined and, to less extent, sensitive
to the initial conditions (in other words, to the molecular con-
text) chosen for performing simulations. These properties make
the obtained genetic interaction networks a good model for the
experimentally-measured ones.
Therefore, we believe that the suggested methodology will
contribute to the toolbox of computational approaches in sys-
tems biology, connected to mathematical modeling of cellular
mechanisms.
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